Navigation Links
Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order

XI'AN, China, July 22 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announced the receipt of its European order for approximately 80 metric tons of Diosmin from Galenicum Health S.L., a Spanish pharmaceutical company. This order is valued at approximately $3.8 million with shipments between August 2010 and July 2011.

Jing'an Wang, the Company's CEO, stated, "I am excited to share news of this purchase order with our investors. HFGB is the only pharmaceutical company in China which has obtained GMP certification and applied for the Certification of Suitability to Monograph of European Pharmacopoeia ("COS") from the European Directorate for the quality of medicine. We currently have customers throughout the world, including France, Japan, South Korea, Australia, Southeast Asia, Russia, India, Germany and the U.S. Once the Company receives COS approval, we believe that the Company will continue to expand its global market share."

About Diosmin

Diosmin is a flavonoid that can be isolated from various plant sources or derived from the flavonoid hesperidin. Diosmin is used as a pharmaceutical material as a supplement to treat chronic venous insufficiency, hemorrhoids, lymphedema, and varicose veins.

About Huifeng Bio-Pharmaceutical Technology, Inc.

Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. More information can be found on the company's web site at:

Forward-Looking Statements:

This press release includes "forward-looking statements" as defined by the Securities and Exchange Commission (the "SEC"), including statements regarding COS certification and shipments of products. All statements, other than statements of historical fact, included in the press release that address activities, events or developments that the company believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on certain assumptions made based on experience, expected future developments and other factors the company believes are appropriate under the circumstances. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the company and may not materialize, including the timeline for COS approval, receipt of COS approval, delays in manufacturing or transporting product. Investors are cautioned that any such statements are not guarantees of future performance.

    For more information, please contact:

    Investor Relations:
     Capital Group Communications, Inc.
     Mr. Kevin Fickle
     Tel:   +1-925-330-8315

    Company Contact:
     Huifeng Bio-Pharmaceutical Technology, Inc.
     Mr. Steven Tong, IR Director
     Tel:   +86-135-721-18351

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase
2. Renhuang to Launch New Bio-pharmaceutical Product - Ginseng and Deer Antler Extract
3. Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology
4. Partnership Brings Breast Image Documentation Technology to Women Around the World
5. ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc.
6. Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver
7. Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010
8. ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
9. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
10. Elsevier Appoints Martin OMalley as Managing Director of New Global Sales Group in Science & Technology Division
11. Recondo Technology Announces Integration Initiative for US Hospital Systems
Post Your Comments:
(Date:11/24/2015)... BOULDER, Colo. , Nov. 24, 2015 /PRNewswire/ ... announced that its Chief Executive Officer, Ron ... Annual Healthcare Conference in New York.  The public ... a webcast on the Array BioPharma website.Event:Piper Jaffray ... OfficerDate:  , Wednesday, December 2, 2015Time:1:30 p.m. Eastern ...
(Date:11/24/2015)... Nueva York , 24 de noviembre de ... del Avery Breathing Pacemaker System, se complace anunciar ... Ph.D. como consultor clínico. ... Foto -   ... Jonzon es un fisiólogo y consultor en neonatología ...
(Date:11/24/2015)... --> --> ... by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich ... Lumbar Interbody Fusion), End User, and Geography - Global Forecast ... at $1.90 Billion in 2014 and is expected to reach ... the forecast period of 2015 to 2020. Browse ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
(Date:11/24/2015)... ... November 24, 2015 , ... The hospitals ... to several aspects of orthopedic care. They have received recognition for excellence from ... orthopedic care. , Becker's Hospital Review selected hospitals for inclusion based on ...
(Date:11/24/2015)... Port Richey, FL (PRWEB) , ... November 24, 2015 , ... ... it deems a growing epidemic as deaths from prescription opioids in the United States ... heroin and cocaine. In 2013 alone, opioids were involved in 37 percent of all ...
(Date:11/24/2015)... ... November 24, 2015 , ... Serenity Point Rehabilitation, a holistic treatment center for ... with some of the staff members at their recovery center. The videos highlight some ... as some of the things that make their recovery program so unique. , “Making ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... award at Cleveland University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, ... Chiropractor and University President Carl S. Cleveland III on October 16. , “Katie ...
Breaking Medicine News(10 mins):